pindolol has been researched along with Agoraphobia in 1 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Agoraphobia: Obsessive, persistent, intense fear of open places.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, SL | 1 |
| Charney, DS | 1 |
| Woods, SW | 1 |
| Heninger, GR | 1 |
| Tallman, J | 1 |
1 other study available for pindolol and Agoraphobia
| Article | Year |
|---|---|
Lymphocyte beta-adrenergic receptor binding in panic disorder.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Agoraphobia; Depressive Disorder; Fear | 1988 |